Brianne Beggs
Nurse Practitioner · Fresno, CANPI 1033341722
Payments from drug & device makers
Across 174 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$436
- AbbVie$378
- Therapeuticsmd, Inc.$280
- Daiichi Sankyo Inc.$274
- Shield Therapeutics Inc$229
- Agile Therapeutics, Inc.$147
- plus $817 from 16 others
What the payments were for
- Food & beverage$2,54499%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 37 | $436 |
| AbbVie | 21 | $378 |
| Therapeuticsmd, Inc. | 27 | $280 |
| Daiichi Sankyo Inc. | 26 | $274 |
| Shield Therapeutics Inc | 11 | $229 |
| Agile Therapeutics, Inc. | 7 | $147 |
| Pfizer | 6 | $123 |
| Evofem Biosciences, Inc. | 7 | $103 |
| Organon | 4 | $86 |
| Myovant Sciences Inc. | 5 | $86 |
| Exeltis, USA Inc. | 4 | $82 |
| Bayer | 4 | $73 |
| Scynexis, Inc. | 2 | $45 |
| Sage Therapeutics, LLC | 2 | $38 |
| Hologic Sales And Service, LLC | 2 | $38 |
| Coopersurgical, Inc. | 2 | $30 |
| Merck | 2 | $24 |
| Astellas Pharma US Inc | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Merz North America, Inc. | 1 | $18 |
| Ascend Therapeutics US, LLC | 1 | $16 |
| Avion Pharmaceuticals | 1 | $15 |
How this compares
$2,562 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 16 | $9,255 |
| Estradiol | 67 | $2,144 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 19 | $1,319 |
| ValacyclovirValacyclovir Hcl | 14 | $1,093 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $123 | $9,25516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Fresno
- Erica BedstedFresno$194K
- Sonja GrowcottFresno$31K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.